Carolyn Langlois

Amyloid-β ¹¹ C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +17

The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohort

Pierre N. Tariot, Francisco Lopera, Jessica B. Langbaum et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 129 citations · Full text

Medicine, Neurology, Pharmacology +17

GeneMatch: A novel recruitment registry using at‐home <i>APOE</i> genotyping to enhance referrals to Alzheimer's prevention studies

Jessica B. Langbaum, Jason Karlawish, J. Scott Roberts et al. · Alzheimer s & Dementia · 2019 · 60 citations · Full text

Medicine, Genetics, Preventive Medicine +17

Alzheimer's Prevention Initiative Generation Program: Development of an <i>APOE</i> genetic counseling and disclosure process in the context of clinical trials

Carolyn Langlois, Angela R. Bradbury, Elisabeth McCarty Wood et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019 · 51 citations · Full text

Medicine, Genetics, Psychology +16

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

Jessica B. Langbaum, Noel Ellison, Angelika Caputo et al. · Alzheimer s Research & Therapy · 2020 · 40 citations · Full text

Medicine, Neurology, Psychology +17